In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives

References

Page 1

	Year	Citations
Modulation of TH1 and TH2 Cytokine Production with the Immune Response Modifiers, R-848 and Imiquimod Tamara L. Wagner, Cory L. Ahonen, Aimee M. Couture, Cellular Immunology InflammationCytokineAllergyAutoimmune DiseaseImmunology	1999	261
Tumor-Selective Induction of Apoptosis and the Small-Molecule Immune Response Modifier Imiquimod Michael P. Schön, Anne B. Bong, Claudia Drewniok, JNCI Journal of the National Cancer Institute	2003	256
Cytokine induction in mice by the immunomodulator imiquimod Michael J. Reiter, Traci L Tester man, Richard L. Miller, Journal of Leukocyte Biology InflammationCytokineAllergyAutoimmune DiseaseMedicine	1994	171
Topical imiquimod treatment of a cutaneous melanomametastasis Alexander Steinmann, Jens Oliver Funk, Gerold Schuler, Journal of the American Academy of Dermatology MelanomaWound HealingDermatologyMedicineTopical Imiquimod Treatment	2000	142
Stimulation of Interferon and Cytokine Gene Expression by Imiquimod and Stimulation by Sendai Virus Utilize Similar Signal Transduction Pathways Klára Megyeri, Wei-Chun Au, I Rosztóczy, Molecular and Cellular Biology	1995	135
Death Receptor-Independent Apoptosis in Malignant Melanoma Induced by the Small-Molecule Immune Response Modifier Imiquimod Michael P. Schön, B. Gregor Wienrich, Claudia Drewniok, Journal of Investigative Dermatology Cancer ImmunosurveillanceApoptosisImmunologyMalignant Melanoma InducedCell Death	2004	127
Imidazoquinoxaline Src-Family Kinase p56<sup>Lck</sup> Inhibitors: SAR, QSAR, and the Discovery of (<i>S</i>)-<i>N</i>-(2-Chloro-6-methylphenyl)-2-(3-methyl-1-piperazinyl)imidazo- [1,5-<i>a</i>]pyrido[3,2-<i>e</i>]pyrazin-6-amine (BMS-279700) as a Potent and Orally Active Inhibitor with Excellent in Vivo Antiinflammatory Activity Ping Chen, Arthur M. Doweyko, Derek Norris, Journal of Medicinal Chemistry ImmunologyPharmacotherapyHeterocycle ChemistryChemical BiologyPharmaceutical Chemistry	2004	55
Regression of lymphomatous skin deposits in a chronic lymphocytic leukemia patient treated with the Toll-like receptor-7/8 agonist, imiquimod David Spaner, Richard L. Miller, Jenny Mena, Leukemia & lymphoma/Leukemia and lymphoma	2005	54
EAPB0203, a member of the imidazoquinoxaline family, inhibits growth and induces caspase-dependent apoptosis in T-cell lymphomas and HTLV-I–associated adult T-cell leukemia/lymphoma Georges Moarbess, Hiba El-Hajj, Youmna Kfoury, Blood	2008	38
Design and synthesis of novel imidazo[1,2-a]quinoxalines as PDE4 inhibitors Carine Deleuze‐Masquéfa, Grégori Gerebtzoff, Guy Subra, Bioorganic & Medicinal Chemistry	2004	32

Page 1